Open AccessEffectiveness and safety of different doses of pioglitazone in psoriasis: a meta-analysis of randomized controlled trials
Author(s) -
Jing-Zhan Zhang,
Ding Yuan,
Xiang Fang,
Shi-Rong Yu,
Dezhi Zhang,
Meng-meng Guan,
Xiaojing Kang
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000642
Subject(s) - pioglitazone , jadad scale , medicine , randomized controlled trial , meta analysis , cochrane library , placebo , confidence interval , psoriasis , odds ratio , diabetes mellitus , type 2 diabetes , endocrinology , alternative medicine , pathology , dermatology
Pioglitazone may be beneficial in the treatment of psoriasis. However, based on the effectiveness and safety considerations, it has not been widely used. To fully evaluate the strength of evidence supporting psoriasis treatment with pioglitazone, we conducted a meta-analysis of existing published studies.